Comparison of Liquid and Tablet Buprenorphine Formulations in Steady-State Pharmacokinetics
Data Collection
Narcotic-Related Disorders+3
+ Mental Disorders
+ Heroin Dependence
Treatment Study
Summary
This study focuses on comparing two forms of buprenorphine, a medication used for treatment, in liquid and tablet form. The research involves individuals who are inducted on either the liquid or tablet version, without knowing which one they are receiving. The goal is to understand the effects of these different forms once they reach a steady state, typically by the second week. This study is crucial as it aims to improve treatment methods and address current challenges associated with buprenorphine use. During the study, participants are scheduled for blood draws in specific weeks. The main outcomes being measured are drug craving, drug use, and retention, which refers to how well the medication stays in the body. These measurements help evaluate the effectiveness and safety of both forms of buprenorphine, potentially aiding in the development of improved treatment strategies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 21 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location